TD1414 2% Cream
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TD1414 2% Cream, covering 2018-07-23 to 2018-07-23. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL) [Phase 2]